Medicine Supply Notification: Trifluoperazine 1mg/5ml syrup (Advanz Pharma) – Update

Medicine Supply Notification: Trifluoperazine 1mg/5ml syrup (Advanz Pharma) – Update

July 28, 2021

Update: (28/07/2021) Further supplies now expected mid-September 2021


Department of Health and Social Care (DHSC) has issued a medicine supply notification for Trifluoperazine 1mg/5ml syrup (Advanz Pharma)

Trifluoperazine 1mg/5ml syrup will be out of stock until April 2021

Trifluoperazine 1mg and 5mg tablets remain available and can support an increase in demand.

Specials manufacturers have confirmed they can manufacture trifluoperazine 1mg/5ml oral suspension.

Trifluoperazine 5mg/5ml oral solution remains available and can support an increase in demand.

When prescribing a product that is not licensed in the UK prescribers must indicate on the FP10 prescription that an unlicensed product is required. This can be done by annotating the prescription with the following wording: “special order”.

There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems. Where a prescriber wishes to prescribe an unlicensed import, a paper prescription should be issued as ‘Trifluoperazine 1mg/5ml oral suspension (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special with the following:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

 



Posted in: ,


More Latest News >